Verrica Pharmaceuticals Inc. Made Big Gain
Wed, Nov 26, 2025 at 07:46 PM
Verrica Pharmaceuticals Inc. (VRCA:NASDAQ) rocketted at $6.71, a gain of 31.1%. On Wed, Nov 26, 2025, VRCA:NASDAQ hit a New 2-Week High of $6.71. The stock appeared on our News Catalysts scanner on Mon, Nov 24, 2025 at 10:47 AM in the 'PRIVATE PLACEMENT' category. From Wed, Nov 12, 2025, the stock recorded 80.00% Up Days and 72.73% Green Days
About Verrica Pharmaceuticals Inc. (VRCA:NASDAQ)
Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 194.42%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 117.39%
- Amber International Holding Limited (AMBR:NASDAQ), 56.33%
- KALA BIO, Inc. (KALA:NASDAQ), 42.63%
- Quantum BioPharma Ltd. (QNTM:NASDAQ), 41.92%
- Mobile-health Network Solutions (MNDR:NASDAQ), 39.47%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 31.05%
- K Wave Media Ltd. (KWM:NASDAQ), 29.59%
- Boqii Holding Limited (BQ:NYSEMKT), 29.55%
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 29.21%